Table of Contents
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Stroke
Pipeline Overview
--% of Projects (By Phase of Development)
--No. of
Projects by Phase of Development
--Marketed Products Vs. Pipeline
Products
Company Overview - Pipeline Projects
--Company Overview -
Pipeline Projects
--Top Companies in late stage Stroke Projects
--Bayer Ag
--Asubio Pharma Co., Ltd.
--D-Pharm Ltd
--Bristol-Myers
Squibb Company
--Imarx Therapeutics, Inc.
--GlaxoSmithKline plc
--Merck & Co Inc
--Johnson & Johnson
--Neurobiological Technologies
Inc
--Mitsubishi Tanabe Pharma Corporation
--Ortho-McNeil, Inc.
--Ono Pharmaceutical Co., Ltd.
--Pfizer Inc
--PAION
--Solvay
S.A.
--Shionogi & Co., Ltd.
--ThromboGenics NV
--Sygnis Pharma
AG
--YUNGJIN PHARM. CO.,LTD
--Vernalis Plc ADR
--Top
Companies in early stage Stroke Projects
--Arbor Vita Corporation
--Amkor Pharma, Inc.
--Celldex Therapeutics, Inc
--BioVascular
Inc.
--GlaxoSmithKline plc
--FibroGen, Inc.
--Imarx Therapeutics,
Inc.
--Halozyme Therapeutics Inc
--La Jolla Pharmaceutical Co
--KAI Pharmaceuticals Inc.
--Ono Pharmaceutical Co., Ltd.
--Novavax
Inc
--PLx Pharma Inc.
--PAION
--Suntory Limited
--Shionogi &
Co., Ltd.
--Trigen Holdings AG
--Torrent Pharmaceuticals Limited
--Xigen S.A.
--Wyeth
Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline
View
--Phase II Pipeline View
--Phase III Pipeline View
--On the
Market Pipeline View
--Discovery/Development Pipeline View